e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of resection surgery on long-term treatment outcomes of patients with MDR/XDR-TB
Y. Batyrshina (Novosibirsk, Russian Federation)
Source:
International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Session:
Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Session type:
Oral Presentation
Number:
4857
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Batyrshina (Novosibirsk, Russian Federation). The effect of resection surgery on long-term treatment outcomes of patients with MDR/XDR-TB. 4857
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Long-term effectiveness of surgery treatment of TB patients
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Treatment outcomes for XDR TB patients with surgery
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
MDR/XDR-TB treatment outcome
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis
Source: Annual Congress 2007 - Controversies in surgical oncology
Year: 2007
Long-term results of a surgical treatment in patients with thymomas
Source: Eur Respir J 2003; 22: Suppl. 45, 368s
Year: 2003
Smoking status and operative and post-operative complications in patients who had undergone resection of pulmonary metastases
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007
Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer
Source: International Congress 2017 – Thoracic surgery
Year: 2017
Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables.
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Preoperative evaluation for patients undergoing lung resection surgery
Source: Eur Respir J 2004; 24: Suppl. 48, 324s
Year: 2004
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT).
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003
Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy
Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery
Year: 2007
Our clinical experience in surgical therapy of patients with bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002
Can we still justify pneumonectomy following induction chemotherapy?
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006
Does induction chemotherapy increase operative risk of pneumonectomy?
Source: ISSN=ISSN 1810-6838, ISBN=, page=66
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept